Obstetric anesthesia

Comparison of the dural puncture epidural and the standard epidural techniques in patients having labor analgesia maintained using programmed epidural boluses: a prospective double-blinded randomized clinical trial

Reg Anesth Pain MedPublished Randomised controlled trial

Primary result · Ropivacaine consumptionResult — go to the resultMean difference −0.724 mg 95% CI −1.450 to 0.001

Authors' conclusion

Our findings suggest that when labor analgesia is maintained using the programmed intermittent epidural bolus method, there is no significant advantage to initiating analgesia using the dural puncture epidural compared with the standard epidural technique.

Study context

Population
Parturients requesting epidural labor analgesia, maintained with ropivacaine 0.1% and sufentanil 0.5 µg/mL via programmed intermittent epidural boluses (8 mL every 40 min)339 completed and analysed
Participants
400 participants
Comparison
Dural puncture epidural vs Standard epidural
Methodological detailsprospective, double-blinded
  • Prospective
  • Double-blinded

Primary result

Ropivacaine consumption

Mean difference

−0.724 mg

95% CI −1.450 to 0.001

P = 0.051

Dural puncture epidural vs Standard epidural
mean difference −0.724 mg (95% CI −1.450 to 0.001); P = 0.051

As reported in the abstract

Further findings

Pain scores, time to first and number of programmed boluses, number of manual boluses, obstetric and neonatal outcomes

No differences between groups

Patient satisfaction

Statistically higher in the dural puncture epidural group but absolute difference small

Original publication

Comparison of the dural puncture epidural and the standard epidural techniques in patients having labor analgesia maintained using programmed epidural boluses: a prospective double-blinded randomized clinical trial. Reg Anesth Pain Med. Published 24 April 2024. doi:10.1136/rapm-2024-105468

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.